Skip to main content
Clinical Trials/CTRI/2024/08/072312
CTRI/2024/08/072312
Not yet recruiting
未知

Evaluation of Optical Coherence Tomography Angiography Parameters following use of Anti vascular endothelial growth factor in Non resolving Central Serous Chorioretinopathy - NIl

Maulana Azad Medical college0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Maulana Azad Medical college
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Treatment naïve subjects in the age group of 25\-50 years having non resolving central serous chrioretinopathy of more than four months duration along with subretinal fluid (SRF) involving fovea on optical coherence topography (oct) and active angiographic leakage of fundus fluorescein angiography (FFA)
  • 2\)Subject having best corrected visual acuity (BCVA) of at least 6/60

Exclusion Criteria

  • 1\)patients having ocular conditions causing accumulation of sub\-retinal fluid like diabetic retinopathy,retinal vascular occlusion,ocular inflammation or ocular conditions causing macular exudation such as pathological myopia and antioxidants streaks
  • 2\)patients who have undergone any intraocular surgery other than uncomplicated cataract extraction
  • 3\)Risk of thrombo\-emboli events and/or occurrence within past 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials